Regenxbio (RGNX) Operating Margin Growth (1y) (2015 - 2026)
Regenxbio (RGNX) Operating Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1,049.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,238.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -10,520.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -1,651.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,002.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,091.00 |
| 10 | Regenxbio | 583.35 Mn | 477.83 Mn | 106.98 Mn | 32,335.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32,335.00 |
| Dec 31, 2025 | 2,984.00 |
| Sep 30, 2025 | 8,028.00 |
| Jun 30, 2025 | -3,975.00 |
| Mar 31, 2025 | 43,014.00 |
| Dec 31, 2024 | 4,554.00 |
| Sep 30, 2024 | -3,189.00 |
| Jun 30, 2024 | 10,945.00 |
| Mar 31, 2024 | -7,052.00 |
| Dec 31, 2023 | -10,338.00 |
| Sep 30, 2023 | 4,331.00 |
| Jun 30, 2023 | -17,443.00 |
| Mar 31, 2023 | -2,375.00 |
| Dec 31, 2022 | -26,297.00 |
| Sep 30, 2022 | -8,161.00 |
| Jun 30, 2022 | 4,548.00 |
| Mar 31, 2022 | -8,871.00 |
| Dec 31, 2021 | 32,884.00 |
| Sep 30, 2021 | -20,046.00 |
| Jun 30, 2021 | 1,551.00 |